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The crystal structure of the Sgt1-
Skp1 complex: the link between 
Hsp90 and both SCF E3 ubiquitin 
ligases and kinetochores
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Tina Daviter1, Stefan H. Millson3, Konstantinos Thalassinos2 & Cara K. Vaughan1
The essential cochaperone Sgt1 recruits Hsp90 chaperone activity to a range of cellular factors including 
SCF E3 ubiquitin ligases and the kinetochore in eukaryotes. In these pathways Sgt1 interacts with Skp1, 
a small protein that heterodimerizes with proteins containing the F-box motif. We have determined 
the crystal structure of the interacting domains of Saccharomyces cerevisiae Sgt1 and Skp1 at 2.8 Å 
resolution and validated the interface in the context of the full-length proteins in solution. The BTB/POZ 
domain of Skp1 associates with Sgt1 via the concave surface of its TPR domain using residues that are 
conserved in humans. Dimerization of yeast Sgt1 occurs via an insertion that is absent from monomeric 
human Sgt1. We identify point mutations that disrupt dimerization and Skp1 binding in vitro and find 
that the interaction with Skp1 is an essential function of Sgt1 in yeast. Our data provide a structural 
rationale for understanding the phenotypes of temperature-sensitive Sgt1 mutants and for linking 
Skp1-associated proteins to Hsp90-dependent pathways.
Proteostasis is critical for the regulation of normal cellular function and its loss is frequently a precursor of disease 
states. Molecular chaperones and their accessory proteins play a crucial role in proteostasis as they enable protein 
folding and activation, as well as direct proteins for degradation via the ubiquitin-proteasome pathway.
Sgt1 is an essential conserved cochaperone of the molecular chaperone Hsp90. It is unique amongst Hsp90 
cochaperones in that it is has been linked genetically and biochemically to both folding and degradation pathways. 
It was first identified via genetic screens as a protein that directly interacts with the small adapter protein Skp1, 
in both the Skp1/Cullin/F-box (SCF) E3 ubiquitin ligase pathway, and in assembly of the essential Saccharomyces 
cerevisiae inner kinetochore complex, Centromere Binding Factor 3 (CBF3)1 (Fig. 1A). These functionally distinct 
pathways share a degree of structural homology: a common feature of both systems is the interaction of Skp1 with 
proteins comprising an F-box motif followed by a Leucine Rich Repeat domain (LRR), known as FBXL proteins. 
In a subset of SCF E3 ubiquitin ligases (hereafter referred to as SCFs), the complex between Skp1 and the FBXL 
protein provides specificity for the substrate to be ubiquitylated2,3. In the yeast kinetochore CBF3 complex of the 
yeast kinetochore, Skp1 forms a heterodimer with the FBXL protein, Ctf134.
Sgt1 has also been implicated in the innate immune response in humans and disease resistance in plants. In 
the former the Nod-like receptors (NLRs), NALP3, Nod1 and Nod2, all known effectors of the human inflam-
matory response, are dependent on Sgt1 activity5,6, whereas in the latter a wide range of disease resistance ‘R’ 
proteins require Sgt1 function7,8. Sgt1 is also required for sensing the plant hormones auxin and jasmonic acid, 
which are effectors of temperature regulation, growth and disease resistance via the TIR19 and COI1 SCFs10. Both 
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TIR1 and COI1 have recently been shown to be clients for the Hsp90-Sgt1 chaperone complex11,12. In addition 
Sgt1 is required for the activation of adenylyl cyclase, Cyr1, in S. cerevisiae and this direct interaction regulates 
morphogenesis and drug-resistance in Candida albicans13.
Recent studies have found that Sgt1 is overexpressed in several cancers, including breast, lung and colon can-
cer, with Sgt1 controlling the stability of the phosphatase PHLPP1 in gastric tumor cells14–16.
In each case these Sgt1-dependent proteins contain an LRR domain which suggest that it is specifically this 
fold that is targeted by Sgt117. This hypothesis is supported by a cochaperone interactome analysis that identified 
LRR-domains are the predominant interactors of Sgt118.
Sgt1 comprises 3 domains connected by variable linkers (Fig. 1B). The N-terminal domain of Sgt1 is predicted 
to have a helical TPR fold (Tetratrico-Peptide Repeat) and is responsible for the interaction with Skp119,20. It is 
also the site of Sgt1 dimerization in S. cerevisiae and plants21,22. By contrast human Sgt1 is monomeric in vitro21. 
The site of interaction with Hsp90 is through the middle domain which adopts a CS fold (Chord-containing pro-
teins and Sgt1). This is linked to the TPR domain by a Variable Region (VR). The structure of the CS domain has 
been solved, both alone by NMR23 and in complex with the N-terminal domain of Hsp90 by crystallography24. 
This Hsp90 interaction appears to have different nucleotide dependencies in different organisms. In humans and 
Caenorhabditis elegans Sgt1 has a higher affinity for Hsp90 in the ATP- or ATPγ S-bound state, while in yeast Sgt1 
the affinity for Hsp90 is higher in the apo and ADP-bound states20,23,25. Lastly, the highly conserved and largely 
unstructured C-terminal SGS (Sgt1-specific) domain provides an Hsp70 binding site12,26 as well as the putative 
site of interaction with proteins containing the LRR fold17. It is also the site of regulatory phosphorylation by CK2 
in yeast and mutation of serine 361 to the phospho-mimetic aspartic acid is lethal27,28. This site is conserved in 
humans although Polo-like kinase 1 has been identified as the relevant kinase in place of CK228.
The structure of the adaptor Skp1 and its function as a component of the SCF complexes has been 
well-characterised29,30. Skp1 has an N-terminal BTB/POZ domain31 that interacts with Cullin1, a structural sub-
unit of the SCF complexes that arranges the substrate and ligase subunits in close proximity, and a C-terminal 
extension of around 35 residues, that folds around the helices of F-box motifs (Fig. 1B)32. The Skp1 - F-box inter-
action is structurally conserved among eukaryotes33.
Figure 1. Interactions and Domain Structure of Sgt1 and Skp1. (A) Sgt1 recruits Hsp90 function to Leucine 
Rich Repeat (LRR)-containing proteins. A subset of LRR proteins contain an F-box motif (FBXL proteins) and 
in these cases Skp1 also interacts with Sgt1. (B) Domain structure of Sgt1 and Skp1 with each domain labeled 
by its structural fold. The individual helices of the TPR motifs within the Sgt1 TPR domain are labeled. The 
crystallised complex is highlighted in a blue box. An unconserved loop in S. cerevisiae Skp1 from residues 36–64 
is shown as a dashed yellow line. Known interaction partners are listed below the domain with which they 
associate.
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Despite the significance of the Sgt1-Skp1 interaction as a key node in the Hsp90 chaperone network, and 
its association with both Hsp90-dependent activation and SCF-degradation pathways, the molecular details of 
this interaction are unknown. To gain further insight into this we have determined the 2.8 Å crystal structure of 
a complex of the interacting domains of yeast Sgt1 and Skp1. Using biophysical and biochemical experiments 
we show that the crystallographic interaction between individual interacting domains is representative of the 
interaction between the full-length proteins in solution. Yeast genetic experiments show that the TPR-mediated 
interaction of Sgt1 with Skp1 contributes an essential function of the cochaperone, and that, by contrast, Sgt1 
dimerization mediated by the TPR-interface identified in vitro is not required for yeast viability.
Results
The Sgt1 TPR domain is sufficient for the interaction with Skp1. Previous studies19,20 have shown 
that the interaction between Sgt1 and Skp1 is primarily mediated by Sgt1’s TPR domain, with some studies sug-
gesting that Hsp90 may be required for this interaction19. The TPR domain is also the site of S. cerevisiae Sgt1 
dimerization in vivo with a reported dimerization Kd of 20 nM21,22.
To confirm that our recombinant full-length Sgt1 is dimeric we carried out sedimentation velocity-analytical 
ultracentrifugation (SV-AUC) from 4.5 to 22.3 μ M Sgt1 (corresponding to 0.2 to 1.0 mg/mL). The AUC data were 
fit to a continuous c(s) distribution model with a single f/fo (Fig. 2A). At these concentrations the main species 
(96–98%) had an average corrected sedimentation coefficient of 4.0 S with a molecular weight corresponding to a 
dimer (theoretical dimer weight 89720 Da) (Supplementary Table S1). A small concentration-dependent change 
in sedimentation coefficient and estimated molar mass was observed which may be attributable to an oligom-
erisation or dissociation event in the timescale of the experiment. We therefore used native nano-electrospray 
mass spectrometry (nESI-MS) at identical concentrations to the SV-AUC experiments to further report on 
the oligomeric state of Sgt1. The spectra were deconvoluted with Amphitrite34 (Fig. 2B) to quantify the con-
tribution of different oligomeric species to the total spectra (Supplementary Table S2). A non-equilibrium, 
concentration-dependent change in the oligomerisation was detected in the gas phase. At these concentrations, 
dimeric Sgt1 is the predominant species (48–69%) with subpopulations of both monomer and trimer. Together 
these results suggest that at experimental working concentrations S. cerevisiae Sgt1 is dimeric in solution with a 
minor population of both monomer and trimer.
To investigate the interaction of Sgt1 with Skp1 using purified proteins in vitro, we compared the affinity 
of Skp1 for full-length Sgt1 and an Sgt1 TPR domain construct (Sgt1TPR, comprising residues 1–150) using 
isothermal titration calorimetry (ITC). Data were fit using a single site model assuming dimeric Sgt1. For both 
full-length Sgt1 and Sgt1TPR a stoichiometry of one Sgt1 dimer to one Skp1 monomer was obtained, with both 
interactions having a Kd of 0.6–0.7 μ M (Fig. 2C,D), confirming that the Sgt1 TPR domain is sufficient for the Skp1 
interaction in vitro. Nonetheless the interactions have distinct thermodynamic signatures suggesting a more com-
plex interaction for the full-length proteins.
Skp1-Sgt1 crystal structure. To investigate the nature of Sgt1 dimerization and its interaction with Skp1 
we carried out crystallization screens for the complex between Sgt1TPR and Skp1. Crystals were obtained that 
diffracted to 2.8 Å (Supplementary Table S3) of a complex comprising Sgt1TPR and a truncated construct of Skp1, 
Skp1BTB∆ . The Skp1BTB∆ construct comprises the N-terminal BTB/POZ domain in which an unconserved 
loop that is predicted to be unstructured (residues 36–64, Fig. 1B) is replaced by an alanine-serine linker.
The asymmetric unit contains 3 copies of Sgt1TPR (chains A, B & C) and a single copy of Skp1BTB∆ (Fig. 3A). 
Chains B & C of Sgt1TPR have continuous electron density from Pro2 to Asn136. Chain A is less well-defined 
with some missing density in loop regions. The Skp1 density is continuous except for residues 65–74, which are 
C-terminal to the Ala-Ser linker described above, and a loop connecting helices 3 & 4.
The Sgt1 TPR domain comprises 3 TPR motifs, each of two antiparallel helices (A & B), and a solvating helix 
(κ ). These pack together in a right-handed superhelix in which the A & B helices form concave and convex faces 
respectively (Fig. 3A). The average RMSD of Cα atoms for the individual subunits within the asymmetric unit 
is 0.49 Å. Structural alignment of Sgt1TPR with TPR domains with high sequence identity to Sgt1 (PPP5, Sgt, 
CTPR3 & Hop TPR1 with PDBs 1A17, 2VYI, 1NAO & 1ELW respectively) reveals that helices 3 A & 2B are 
extended compared to canonical TPR motifs, by one and two helical turns respectively. In addition there is an 
insertion of 8 amino acids between helices 2 A & 2B that includes the turn of a 310 helix. Sequence alignment of 
Sgt1 homologs suggests that these differences are specific to ascomycete fungi and are absent from metazoans and 
plants (Supplementary Figure S1).
The overall structure of the BTB/POZ domain of Skp1 in this complex is largely unchanged compared with 
previously determined structures (RMSD = 0.914 Å)33,35. It comprises 2 subdomains: an N-terminal subdomain 
of a 3-stranded β -sheet packed on top of helices α 1 and α 2, and a C-terminal subdomain of 2 pairs of anti-parallel 
helices packed perpendicular to each other.
Analysis of the interfaces in the crystal using the EPPIC server36, which uses a combination of conservation 
and geometry-based metrics to distinguish crystallographic from biological interfaces, suggest that the interfaces 
within the asymmetric unit are likely to be biologically relevant. Composite omit maps for these interfaces are 
shown in Supplementary Figure S2.
Skp1 binds in the concave face of the Sgt1 TPR domain. A single copy of Sgt1TPR contributes the 
entire interaction interface with the N-terminal subdomain of Skp1BTB∆ . Skp1 sits within the upper half of the 
concave face generated by the Sgt1 TPR motif repeats (Fig. 3A). Residues from the α 2-helix and β 3-strand of 
Skp1BTB∆ form the interface with residues from Sgt1 TPR1A, 2 A, 3 A and the capping helix.
The Sgt1TPR-Skp1BTB∆ interface in the asymmetric unit buries 597.6 Å2. Although relatively small for a 
protein-protein interface, all charged, polar and hydrophobic Skp1 interfacial residues are either completely or 
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Figure 2. Biophysical Characterisation of Sgt1 and Its Interaction with Skp1. (A) c(s) distributions for 
Sgt1 FL at 4.5 μ M, 11.2 μ M & 22.3 μ M monomer and corresponding boundary fits and residuals for the 
sample at 4.5 μ M generated by SV-AUC. Supplementary Table S1 details the sedimentation coefficients, 
MW and f/fo. (B) Native nESI-MS spectra of full-length Sgt1 at 4.5 μ M, 11.2 μ M and 22.3 μ M. Charge state 
series corresponding to monomer, dimer, and trimer are indicated in grey, blue and purple respectively. 
Charge states: wt + 13 ○ , (wt)2 + 20 ● , (wt)3 + 24 ♦ . Spectra were deconvoluted to individual charge 
state series using Amphitrite34 with the raw data shown in black and the sum of simulated spectra in red. 
Supplementary Table S2 details the percentage contribution of individual species at each concentration.  
(C) Left: Raw isothermal titration calorimetry (ITC) data for the interaction between full-length Sgt1  
(12 μ M dimer) and full-length Skp1 (160 μ M) at 25 °C. Right: Dilution-corrected and integrated heats for the 
ITC data are fitted according to a single binding site model assuming dimeric Sgt1. (D) As Figure C but for 
the interaction between Sgt1TPR (10 μ M dimer) and full-length Skp1 (140 μ M) at 25 °C.
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strongly conserved throughout fungi, metazoans and plants with the exception of Leu28, which is a threonine in 
all other species. Three central residues at the Sgt1 interface are strongly conserved: Arg93 is strictly conserved, 
Trp127 is strongly conserved (Trp in metazoans and Leu in plants), and Tyr15, which interacts with Skp1 via its 
benzyl group, is Leu in most metazoans and Phe in plants (Supplementary Figure S1).
In this interface the α 2-helix of Skp1BTB∆ is amphipathic and forms a bipartite interface with Sgt1 in which 
half is hydrophobic, and half is electrostatic (Fig. 3B). Residues Lys30 and Asp35 of Skp1 contribute salt bridges 
with Asp16 and Arg93 of Sgt1 (Supplementary Figure S2). These electrostatic interactions are supported by 
additional hydrogen bonds between Tyr11, Tyr15, Lys50, Asn100 of Sgt1 and Asn34 and Asp35 of Skp1. The 
hydrophobic core is formed by the other side of the amphipathic α 2-helix, with Leu28, Leu29 and Tyr32 of Skp1 
interacting with Thr123, Leu126 and Trp127 on the capping helix of Sgt1. Met77 and Pro78 on the β 3-strand of 
Skp1BTB∆ also contribute to this interface.
To test our observations in the context of the full-length proteins in solution we mutated Sgt1 residues at 
the Sgt1-Skp1 interface and investigated the ability of these His6-tagged Sgt1 mutants to interact with untagged 
wild-type Skp1 in a pulldown assay (Fig. 3C). Mutation of highly conserved Arg93 and Trp127 to Ala results in 
complete loss of binding of the full-length proteins in solution, whereas mutation of Leu126, a poorly conserved 
residue contributing a van der Waals interaction at the edge of the interface, to Ala, does not significantly affect 
binding compared to the WT. These results are consistent with the crystallographic interface providing the pri-
mary interaction between full-length Sgt1 and Skp1 in solution.
Figure 3. Crystal Structure of The Skp1 TPR Domain in Complex With Skp1. (A) The asymmetric unit 
of the complex contains 3 subunits of Sgt1TPR (different shades of blue) and one Skp1BTB∆ (yellow). The 
individual TPR motifs are labeled within each TPR domain. Loops that are not visible in the crystal structure 
are shown as dashed lines. (B) The Sgt1TPR-Skp1BTB∆ interface. Residues that make the closest van der 
Waals contacts and hydrogen bonds are shown. Domains coloured as (A). (C) Pulldown of full-length 
Skp1 using His6-tagged wild type Sgt1 (WT) and indicated mutants on Ni resin. L = 10% load, B = bound. 
* = Degradation products of Sgt1 that copurify with the full-length protein. The full-length gel is presented in 
Supplementary Figure S6A.
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A conserved charged sequence is essential for the Sgt1-Skp1 interaction. In S. cerevisiae an 
unconserved low sequence complexity region (LCR), comprising residues 36–64 is followed by an acidic stretch 
of aspartate and glutamate residues that is also partially conserved in metazoans (residues 69–74) (Fig. 4A). 
The LCR does not contribute essential function since human Skp1, in which the LCR is absent, can rescue the 
temperature-sensitive growth of the skp1–12 mutant37. Complexes with Skp1 including the LCR were refractory 
to crystallization, probably as a consequence of its predicted disorder. This has also been observed in previously 
determined Skp1-F-box crystal structures32,33. In our Sgt1TPR-Skp1BTB∆ structure the LCR is replaced by an 
alanine-serine linker and electron density for the alanine is visible at the edge of the Sgt1-Skp1 interface.
Electron density was missing for residues 65–74, immediately adjacent to the truncated LCR, despite being 
present in the crystallised construct. Since the disorder of this conserved segment in the crystal structure may 
be a consequence of the LCR truncation, possibly by restricting the conformational space available, we tested if 
these residues may contribute to the interaction with Sgt1 in the context of the full-length proteins. We generated 
two mutants of Skp1, referred to as Skp1∆ 1 and Skp1∆ 2 (Fig. 4A). In both mutants the LCR residues are retained 
but in Skp1∆ 1 residues 65–74 are deleted, whereas in Skp1∆ 2 they are replaced by a series of alanine and lysine 
residues that introduce a charge reversal of equivalent length. ITC of these mutants, at concentrations equal to 
those used to assess the affinity of the Sgt1- Skp1 WT complex, shows that Skp1∆ 1 has a weaker interaction with 
Sgt1 than the wild-type protein (Fig. 4B) although since the integrated curve has poorly defined plateaus, the esti-
mated Kd for this mutant is limited by the quality of the fit. By contrast no binding isotherm could be detected for 
Skp1∆ 2 (Fig. 4C). These results suggest that, although disordered in the crystal, the conserved charged sequence 
from residues 65–74 does contribute positively to the interaction between Sgt1 and Skp1. The surface of Sgt1 in 
the vicinity of this missing region (near Val76) may provide a binding surface for some of these acidic residues 
(Fig. 4D) as it is predominantly basic, and several of the residues contributing to this patch (Lys102 & Arg 130) 
are conserved in higher eukaryotes.
Yeast specific insertions in the Sgt1 TPR domain are responsible for in vitro oligomerization. 
Dimerization of Sgt1 has been reported to play a role in the assembly of the yeast kinetochore, with 
temperature-sensitive mutants that disrupt dimerization in vivo having an increased chromosome missegregation 
phenotype22. This may be a consequence of impaired formation of the kinetochore complex CBF327. We therefore 
investigated if this dimerization interface was represented in our crystal structure.
The three copies of Sgt1TPR in the asymmetric unit form two identical dimeric interfaces (between C-A 
and A-B) with an rmsd of 1.46 Å in an all-atom superposition (Supplementary Figure S1). The average interface 
area is 601.5 Å2 (C-A = 596.5 Å2; A-B = 606.5 Å2) and occurs via a perpendicular arrangement of subunits in 
which the convex face of one protomer packs against the intra-TPR loops of another. The yeast specific inser-
tion between TPR2A and 2B of both protomers contributes the majority of the interactions of this interface 
(Supplementary Figure S1). At its core His59 makes both a salt-bridge with Asp57 and a cation-π interaction with 
Trp58 on the other protomer (Fig. 5A). This is supported by additional van der Waals interactions between Thr63 
and Phe53. These residues are highly conserved amongst ascomycetes (Supplementary Figure S1). The periphery 
of the interface comprises a number of H-bond interactions including from Asp57, Ser60 and Asp61, all located 
in the loop insertion, bonding to His59, Asn100 and Arg130 respectively (Fig. 5A).
In order to test whether the interface is relevant in full-length Sgt1 the mutations His59 to Ala and Asp61 
to Arg were introduced into an N-terminal His6-tagged full-length Sgt1 and their effects on dimerization were 
assessed. In size exclusion chromatography (SEC), Sgt1-H59A has a larger elution volume than WT, indicative 
of a smaller oligomeric state, whereas Sgt1-D61R has an elution volume intermediate between the two (Fig. 5B). 
These qualitative results are consistent with the contribution of each residue to the interface: His59 contributes 
two interactions at the centre of the interface, and its mutation disrupts dimerization of Sgt1; Asp61 forms a 
peripheral salt-bridge and mutation of this residue causes a mixture of higher and lower oligomers that intercon-
vert on the timescale of the experiment.
Since all full-length Sgt1 constructs elute at a larger volume than expected for their molecular weight, probably 
due to an elongated structure, quantitative results were obtained from SV-AUC and nESI-MS experiments. The 
corrected sedimentation coefficient of 4.4 S for His6-Sgt1 WT reflects a slight increase in the c(s) compared to the 
untagged WT protein, as a consequence of the N-terminal His6 tag. The H59A mutant has a corrected sedimen-
tation coefficient of 2.5 S, with an estimated molecular weight 41 kDa indicating a monomeric species (Fig. 5C, 
Supplementary Table S1). nESI-MS also shows that the H59A mutation significantly disrupts the oligomerization 
and that this mutant of Sgt1 is predominantly monomeric (Fig. 5D, Supplementary Table S2). By contrast, the 
D61R mutant retains some wild-type characteristics with a major population of dimer, but with a loss of trimer 
relative to wild-type. Therefore the solution and nESI-MS data support the crystallographic interface as contrib-
uting to the oligomerisation of full-length Sgt1 in vitro.
The presence of a small population of trimers of full-length Sgt1 as determined by nESI-MS and the obser-
vation of 3 copies of the TPR domain in the asymmetric unit suggests that this oligomerisation state is par-
tially accessible to the full-length protein but is restricted due to steric crowding from the CS and SGS domains. 
To investigate this possibility, the oligomeric properties of the Sgt1TPR construct were tested using SV-AUC, 
nESI-MS and SEC-MALS (Supplementary Figure S3). All three techniques highlight a propensity for this con-
struct to form concentration-dependent trimers, supporting the conclusion that the artificial truncation of the CS 
and SGS domains relieves steric crowding allowing trimer formation in the TPR domain construct.
Skp1 interaction is a requirement for the essential Sgt1 function in yeast. Given the significance 
of the interaction between Sgt1 and Skp1 for the SCF pathway and for assembly of the yeast kinetochore1,38 we 
sought to validate our crystallographic and biophysical data in vivo. Wild type Sgt1-His6 expressed under the Sgt1 
native promoter as the sole Sgt1 in yeast provided functionality, and the strain was not temperature-sensitive. 
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Figure 4. Contribution of a Charged Sequence to Sgt1-Skp1 Association. (A) Sequence alignment of Skp1 
homologs including the Skp1BTB∆ (Skp1BTBd36–64) construct used for crystallization, Skp1∆ 1 (Skp1d1) and 
Skp1∆ 2 (Skp1d2) mutants. S. cerevisiae Skp1 has a loop (green) that is not conserved in higher eukaryotes. The 
loop is replaced by an Ala-Ser linker (cyan) in Skp1BTB∆ . The mutated residues in Skp1∆ 2 are coloured magenta. 
White text on a red background indicates strict identity, red text indicates similarity in a group, a blue frame 
indicates similarity across groups. Residues that contribute to the interface between Sgt1 and Skp1 are shown as 
red triangles. Generated using ESPript56. (B) Left: Raw ITC data for the interaction between Sgt1 (13 μ M dimer) 
and Skp1Δ 1 (130 μ M) at 25 °C. Right: Dilution-corrected and integrated heats for the ITC data are fitted according 
to a single binding site model assuming dimeric Sgt1. (C) As Figure B but for the interaction between Sgt1 (12 μ M  
dimer) and Skp1∆ 2 (145 μ M) at 25 °C. (D) The complex of Sgt1TPR (electrostatic surface potential ± 10 kT/e), 
generated using PDB2PQR and APBS57,58 and Skp1BTB∆ (shown in cartoon). The unconserved deleted loop 
(residues 36–64) and following acidic stretch (residues 65–73) are shown as a dotted line.
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Figure 5. The Sgt1 Dimerization Interface. (A) A detailed view of the oligomerization interface of Sgt1TPR. 
Residues that make the closest van der Waals contacts and hydrogen bonds are shown. (B) Size exclusion 
chromatography of full-length wild-type Sgt1 and the mutants H59A and D61R at 22.3 μ M. Molecular weight 
standards for the column are shown above the chromatograph. (C) The c(s) distribution for full-length His6-
tagged WT and H59A Sgt1 at 11.2 μ M in SV-AUC and corresponding boundary fits and residuals for the 
H59A mutant. (D) Native nESI-MS spectra of the full-length Sgt1 H59A and D61R mutants. Charge states: 
monomer + 14 ○ ; dimer + 20 ● ; trimer + 24 ♦ . Data were deconvoluted with Amphitrite34 and are represented 
directly below each spectrum. The raw data are shown in black and the sum of simulated spectra in red. Charge 
state series corresponding to monomer, dimer, and trimer are indicated in grey, blue and purple respectively. 
Supplementary Table S2 details the percentage contribution of individual species at each concentration.
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The mutations R93A and W127A at the Sgt1TPR-Skp1 interface that prevented the interaction of the full-length 
proteins in vitro were not viable, as seen by absence of growth at restrictive (37 °C) and non-restrictive (28 °C) 
temperatures (Fig. 6A). However the mutations H59A and D61R that completely or partially disrupted oligomer-
ization of Sgt1 in vitro were both found to provide viability and were not temperature-sensitive. Wild type and 
mutant Sgt1 proteins expressed under the Sgt1 promoter were expressed to comparable levels (Fig. 6B). These 
in vivo results support our in vitro analysis, confirming the residues shown to be important for the interaction 
between Sgt1 and Skp1 in our crystal structure are vital for the Sgt1-Skp1 interaction in vivo and that this inter-
action is essential for Sgt1 function.
Discussion
Sgt1 is an essential cochaperone of Hsp90 yet it is poorly characterized at both structural and mechanistic levels. 
We present the crystal structure of the TPR domain of Sgt1 with Skp1, an interaction partner that connects Sgt1 
to kinetochore assembly and SCF activity in S. cerevisiae1.
Our ITC experiments show that a single Skp1 interacts with the TPR domain of the Sgt1 dimer (Fig. 2C,D), 
and our crystal structure indicates that only one TPR domain within the Sgt1 dimer contributes to this interac-
tion (Fig. 3A). A pivotal interaction in this interface is a salt-bridge between Sgt1-Arg93 and Skp1-Asp35, and 
our structure-guided mutagenesis experiments using full-length proteins show that mutation of Arg93 alone 
is sufficient to prevent Skp1 binding in vitro (Fig. 3C) and cause loss of viability in vivo (Fig. 6). Together these 
data support the conclusion that the primary Sgt1-Skp1 interface utilizes the concave groove of the TPR domain 
identified in the crystal structure.
The interaction of Skp1 with full-length Sgt1 has a smaller exothermic component (Fig. 2C,D) than the inter-
action with Sgt1TPR, indicative of enthalpic contributions from residues outside of the TPR domain of Sgt1. 
These could arise from either additional Skp1 contacts outside the TPR domain, or conformational changes in 
full-length Sgt1 on association with Skp1 that are not recapitulated in the interaction of the TPR domain alone. 
Immunoprecipitation studies in reticulocyte lysates of in vitro translated Sgt1 truncations suggest that both pos-
sibilities could occur19, however since the consequences of the R93A mutation in Sgt1 are so striking in all our 
experiments, the latter is the more likely scenario. A detailed understanding of any such conformational changes 
will require structural information for full-length Sgt1.
Many Hsp90 cochaperones contain TPR domains that interact with Hsp90’s C-terminal MEEVD motif39–43. 
Central to this interaction is the “carboxylate clamp”, in which the carboxylates of the C-terminus and the 
sidechain of the final aspartate are anchored by basic and polar residues from each repeat within the concave face 
of the TPR domain. Specifically, a lysine and an asparagine from TPR1A, an asparagine from TPR2A and a lysine 
from TPR3A are typically conserved in TPR cochaperones. A structure-based sequence alignment of the Sgt1 
TPR domain with MEEVD-interacting cochaperones (Supplementary Figure S4) shows that three out of these 
four conserved residues are not found in Sgt1, explaining the lack of interaction with the Hsp90 MEEVD-motif. 
Instead the CS domain of Sgt1 interacts with the N-terminal domain of Hsp9024. The fourth residue, Lys8 on 
TPR1A of Sgt1, is conserved but is remote from the Skp1 interface.
In addition, in many MEEVD-TPR interfaces a further two electrostatic contributions are made: from a lysine 
on TPR2A and an arginine of TPR3A to the first glutamate and the backbone of the MEEVD peptide respectively. 
Both of these residues (Lys50 and Arg93) are conserved in Sgt1 and contribute to the Skp1 interface (Fig. 3B). 
Figure 6. Yeast genetic analysis. (A) Growth of S. cerevisiae JJ345 cells expressing wild-type (WT) Sgt1 or 
indicated mutants. Overnight 28 °C SD-Trp cultures were serially diluted, then pinned onto SD-Trp agar and 
photographed after 2 days of growth at 28 °C and 37 °C. (B) Analysis of Sgt1 level in 28 °C SD-Trp cultures 
expressing WT Sgt1 and either WT or mutant Sgt1-His6. Actin was measured as a loading control. Full-length 
blots are presented in Supplementary Figure S6B.
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Arg93 plays a critical role as its mutation results in the complete loss of interaction with Skp1 in pulldown assays 
(Fig. 3C) and, most significantly, the loss of viability in vivo (Fig. 6).
The truncated, non-essential, unconserved LCR (residues 36–64) and a partially conserved stretch of acidic 
polypeptide (residues 66–74) are positioned at the edge of the interface in the crystal structure. These regions 
of Skp1 may enlarge the interface between the full-length proteins and our ITC analysis (Fig. 4) supports this 
conclusion, since both deletion and mutation of the acidic residues negatively affects the dissociation constant 
of the full-length proteins. In addition, several crystal structures of MEEVD-interacting TPR cochaperones39–43, 
the methionine of the MEEVD motif binds in a shallow hydrophobic pocket on the concave face of the TPR. 
The proximity of the truncated methionine, Met36, to the highly conserved Sgt1-Trp127, suggests that a similar 
mechanism could contribute to the interface in the full-length complex.
Mapping the location of mutations that give rise to temperature-sensitive (ts) phenotypes to the domain struc-
ture of Sgt1 shows that those within the TPR domain cause a G2/M arrest phenotype associated with impaired 
kinetochore formation1,19. The structure presented here of the interacting domains of Sgt1 and Skp1 provides a 
structural basis for understanding these in vivo observations.
All G2/M mutant alleles result in either the replacement of a leucine with a proline in a helix, which will result 
in helix unfolding (sgt1–3, sgt1–6, sgt1–7) (e.g. Supplementary Figure S1), or the introduction of a polar residue 
in a hydrophobic core (sgt1–12). Such structurally disruptive mutations are likely to destabilize the domain, and 
as such cause partial loss of both dimerization and Skp1 interaction. Indeed all TPR domain ts-mutants report-
edly lose Skp1 interaction in a yeast two-hybrid screen19. Our data suggest that the G2/M phenotype of Sgt1 
ts-mutants is a consequence of disruption of Skp1 association with Sgt1, rather than its self-association, as dis-
ruption of the dimerization interface that we identified in vitro does not result in temperature sensitivity (Fig. 6). 
In addition, our monomeric Sgt1 H59A mutant can pull-down Skp1 as efficiently as WT in an in vitro assay using 
purified proteins (Supplementary Figure S5).
However since derivatives of G2/M mutant alleles can be rescued by attaching an artificial dimerization 
domain22, and as phosphorylation of the C-terminal SGS domain of yeast Sgt1 negatively regulates both dimeri-
zation and the association with Skp1 in vivo27 (despite the modification being remote from the dimerization inter-
face identified in our crystal structure) we cannot exclude the possibility that additional or different dimerization 
interfaces exist in vivo.
G2/M mutant Sgt1 alleles display benomyl sensitivity, chromosome missegregation and loss of CEN DNA 
binding by the CBF3 complex of the yeast kinetochore1.Within CBF3, Skp1 forms a heterodimer with the FBXL 
Ctf134 which is an Hsp90 client protein19,44,45 comprising an N-terminal F-box and C-terminal LRR domain. 
Superposition of the Skp1-Skp2 complex32, the closest homologous complex of known structure, on the 
Sgt1TPR-Skp1BTB∆ crystal structure shows that the interactions of Skp1 with both Sgt1 and Skp2 are struc-
turally compatible (Supplementary Figure S4), as demonstrated biochemically24. The Sgt1-Skp1 complex can 
therefore form a direct bridge between FBXL proteins, such as Ctf13, and Hsp90.
The Sgt1-Skp1 complex is also implicated in the SCF pathway in S. cerevisiae. In the active SCF E3 ubiquitin 
ligase, Skp1 interacts both with a substrate-recruiting component and Cul1, which is a structural scaffold for the 
E3 ligase component of the enzyme. The superposition of the Sgt1TPR-Skp1BTB∆ structure with the Skp1-Cul1 
complex31 (Supplementary Figure S4) reveals that both Cul1 and Sgt1 share a common interaction surface on 
Skp1, and that they would therefore compete for Skp1 binding. In humans, Cul1 will displace Sgt1 from Skp1, as 
the Cul1-Skp1 interaction is 2 orders of magnitude tighter than the Sgt1-Skp1 interaction24. Since unlicensed SCF 
activity would be detrimental to the cell, specificity of substrate binding to SCF complexes is tightly controlled by 
a range of mechanisms, including phosphorylation of the substrate and interaction with adaptor molecules46. The 
Sgt1-Skp1 interaction may therefore serve to provide an additional layer of regulation.
In humans and plants Sgt1’s function in the SCF E3 ligase pathway is conserved, and both Sgt1 and Skp1 have 
been also shown to be required for efficient kinetochore formation in humans47. The Sgt1TPR-Skp1BTB∆ crystal 
structure presented here provides an additional piece of the structural jigsaw that links Hsp90 to these pathways. 
However the function of Sgt1 in each system may be context dependent and will require a molecular understand-
ing of how Sgt1 interacts with client proteins and mechanistic details of Hsp90 function in these pathways.
Methods
Protein Expression and Purification. Untagged full-length Skp1 from S. cerevisiae in pET22b was a gift 
from Martin Singleton. Untagged Skp1BTB∆ (residues 1–158) was subcloned using NdeI and BamHI sites into 
pRsetA with a deletion of residues 34–64 and replaced by Ala-Ser. We have used full-length numbering of Skp1 
for residues C-terminal to the loop deletion. Expression of the full-length Skp1 and Skp1BTB∆ was performed 
in BL21 Star (DE3) (Invitrogen) and T7 Express LysY/Iq (NEB) respectively, supplemented with the pRARE 
(Novagen) plasmid.
Untagged full-length Sgt1 and Sgt1TPR (residues 1–150) from S. cerevisiae were cloned in MCSII of 
pColA-Duet (Novagen) using NdeI and BamHI. His-tagged full-length Sgt1 and mutants thereof were cloned 
into pET28a (Novagen) using NdeI and XhoI. Untagged full-length Sgt1 was expressed in BL21 Star (DE3); all 
other constructs were expressed using T7 Express LysY/Iq.
All protein expression was induced with 1 mM IPTG and was continued overnight at 18 °C. Skp1 constructs 
were purified by 2 rounds of anion exchange (HiTrap Q HP, GE Healthcare) followed by gel filtration (Superdex 
75, GE Healthcare) in 50 mM Tris pH 7.5, 2 mM DTT, 1 mM EDTA, 150 mM NaCl. Untagged Sgt1 constructs 
were purified using 2 rounds of cation exchange (HiTrap SP FF, GE Healthcare) followed by gel filtration (either 
Superdex 200 or Superdex 75 depending on construct molecular weight) in 25 mM HEPES pH7.0, 150 mM NaCl, 
2 mM DTT, 1 mM EDTA. For the purification of His-tagged Sgt1 constructs cation exchange was replaced with 
a single HisTrap FF (GE Healthcare) column in a buffer of 50 mM Tris pH7.5, 300 mM NaCl, 10% glycerol. The 
remaining steps were as for the Sgt1 untagged constructs.
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Isothermal Titration Calorimetry. A VP-ITC Microcalorimeter (MicroCal) was used for ITC experi-
ments. All proteins were buffer exchanged into 20 mM HEPES pH7.0, 150 mM NaCl, 1 mM β -mercaptoethanol. 
Typically 20 injections of 130–160 μ M Skp1 were injected into 6–13 μ M Sgt1 dimer at 25 °C. Heats of dilution 
were subtracted and data fitted assuming a single site per Sgt1 dimer allowing three floating variables (stoichi-
ometry, binding constant and enthalpy). Heats of dilution were measured by injecting Skp1 into buffer. Data was 
corrected for Skp1 dilution into buffer alone, and integrated using Origin software. The integrated heats were 
fitted using nonlinear regression using a single site model.
Crystallisation, data collection and structure determination. Purified Sgt1TPR and Skp1BTB∆ 
were mixed in a 2:1 molar ratio and concentrated to 32 mg/mL total protein and crystallised using vapour dif-
fusion. Rod shaped crystals were obtained in 0.325 M MgCl2, 22.5% PEG-6000, 0.1 M Tris-HCl pH 8 at 4 °C. 
Crystals were frozen using 20% ethylene glycol as a cryoprotectant. Data were collected to 2.8 Å at IO4, Diamond 
Light Source, UK. Data were processed using XDS48,49. Molecular replacement attempts using either an ensemble 
of homologous TPR domains or Skp1 failed, therefore crystals were grown with SeMet-Sgt1TPR and unlabelled 
Skp1BTB∆ and a SAD dataset was collected. Initial phases were obtained from the AUTO-Rickshaw server49,50, 
which placed 6 selenium atoms using SHELXD in the spacegroup P3221. 88.9% of the TPR scattering mass in the 
asymmetric unit was built into electron density automatically using HELICAP and BUCCANEER. Molecular 
replacement using Phaser51 was then used to place the Skp1BTB∆ domain. The remaining model was built in 
COOT52 and refined in Buster (Bricogne et al., 2011) using automatic NCS restraints53 and TLS parameters. Data 
collection and refinement parameters are listed in Supplementary Table S3. Simulated annealing omit maps at key 
interfacial residues were calculated in Phenix and are shown in Supplementary Figure S2.
Mass Spectrometry. Prior to mass spectrometry analysis, samples were buffer exchanged into 150 mM 
ammonium acetate pH 7, using Micro Bio-Spin 6 columns (BioRad, Herts. UK). Mass spectrometry experi-
ments were carried out on a first generation Synapt HDMS (Waters Corp., Manchester, UK) mass spectrometer54. 
Instrumental parameters were as follows: source temperature 40 °C, capillary voltage was optimized between 0.9–
1.2 kV, cone voltage 80 V, TriWave trap and transfer voltages were kept at a constant 5 and 10 V respectively. Data 
acquisition and processing were carried out using MassLynx 4.1 software (Waters Corp., Milford, MA, USA). 
Deconvolution of oligomerization states was performed using Amphitrite34.
In vitro protein pulldown assays. All incubations were carried out in 25 mM HEPES pH 7, 100 mM NaCl. 
60 μ l of Ni Sepharose HP Resin (GE healthcare) was blocked with 1 mg/mL BSA and then pre-incubated with 
9 nmoles purified His-Sgt1 (wild-type or mutant) for 1 hour before addition of 20 nmoles of purified Skp1 for a 
further hour. Resin was washed three – four times with buffer and the reaction eluted with SDS-PAGE loading 
buffer.
Sedimentation Velocity Analytical Ultracentrifugation. SV-AUC was carried out using a 
ProteomeLab XL-I (Beckman Coulter) analytical ultracentrifuge at 20 °C. Eight-cell (An-50 Ti) or four-cell (An-
60 Ti) rotors (Beckman Coulter) with 12-mm cells were used at a velocity of 42000 or 60000 RPM respectively. 
Absorbance data were collected at 280 nm. Protein partial specific volume, buffer density and viscosity were 
calculated using SEDNTERP (Laue et al., 1992). The Lamm equation was used to fit sedimentation boundaries of 
200 scans in SEDFIT (Schuck, 2000) using a c(s) with one discreet component.
Genetic Analysis. The yeast strain JJ34555, maintained with a URA3 plasmid-based Sgt1, was transformed 
with a TRP1 plasmid comprising C-terminally His6 tagged wild-type and mutant Sgt1 under its own promoter 
and cured of the URA vector with 5-FOA. Protein levels were determined by Western blot using anti-TetraHis 
antibody and actin used as a loading control. Temperature sensitivity was determined by spotting 5-fold dilutions 
of cells onto plates and growing at control (28 °C) and heat stress (37 °C) temperatures and imaged after two days.
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